Receptor oligomerization and beyond: a case study in bone morphogenetic proteins
暂无分享,去创建一个
Joachim Nickel | W. Sebald | J. Nickel | T. Mueller | Walter Sebald | Kai Heinecke | A. Seher | W. Schmitz | Kai Heinecke | Axel Seher | Werner Schmitz | Thomas D Mueller
[1] W. Sebald,et al. Functional epitope of common γ chain for interleukin-4 binding , 2002 .
[2] N. Ueno,et al. A Kinase Domain-truncated Type I Receptor Blocks Bone Morphogenetic Protein-2-induced Signal Transduction in C2C12 Myoblasts* , 1997, The Journal of Biological Chemistry.
[3] W. Sebald,et al. Cooperativity of Binding Epitopes and Receptor Chains in the BMP/TGFß Superfamily , 2001, Biological chemistry.
[4] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[5] S. Choe,et al. Structure of the ternary signaling complex of a TGF-β superfamily member , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Sebald,et al. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. , 1996, European journal of biochemistry.
[7] M. Sporn,et al. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. , 1984, The Journal of biological chemistry.
[8] W. Kwiatkowski,et al. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. , 2003, Molecular cell.
[9] J. Pohl,et al. Cloning and expression of recombinant human growth/differentiation factor 5. , 1994, Biochemical and biophysical research communications.
[10] A. Kotzsch,et al. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor , 2007, BMC Structural Biology.
[11] K. Miyazono,et al. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor , 1993, Cell.
[12] T. Kirsch,et al. Crystal structure of the BMP-2–BRIA ectodomain complex , 2000, Nature Structural Biology.
[13] Y. Henis,et al. Initiation of Smad-Dependent and Smad-Independent Signaling via Distinct BMP-Receptor Complexes , 2003, The Journal of bone and joint surgery. American volume.
[14] C. Niehrs,et al. Silencing of TGF-β signalling by the pseudoreceptor BAMBI , 1999, Nature.
[15] S. Choe,et al. A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors. , 2004, Molecular cell.
[16] F Layher,et al. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. , 2005, Bone.
[17] A. Reddi,et al. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. , 1997, Cytokine & growth factor reviews.
[18] K. Miyazono,et al. Characterization of type I receptors for transforming growth factor-beta and activin. , 1994, Science.
[19] J. Massagué,et al. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors , 1992, Cell.
[20] J. I. Izpisúa Belmonte,et al. BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors. , 2007, Biochemistry.
[21] M. Alaoui-Ismaili,et al. BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells* , 2008, Journal of Biological Chemistry.
[22] K. Nakamura,et al. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. , 1999, Experimental cell research.
[23] A. Kotzsch,et al. Crystal structure analysis reveals a spring‐loaded latch as molecular mechanism for GDF‐5–type I receptor specificity , 2009, The EMBO journal.
[24] Anja Nohe,et al. The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* , 2002, The Journal of Biological Chemistry.
[25] A. Bradley,et al. Cloning of the human activin receptor cDNA reveals high evolutionary conservation. , 1992, Biochimica et biophysica acta.
[26] K. Miyazono,et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Waage,et al. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells , 2004, Oncogene.
[28] T. Kirsch,et al. BMP‐2 antagonists emerge from alterations in the low‐affinity binding epitope for receptor BMPR‐II , 2000, The EMBO journal.
[29] K. Miyazono,et al. Divergence and convergence of TGF‐β/BMP signaling , 2001, Journal of cellular physiology.
[30] M. Kohno,et al. Distribution and Characterization of Specific Cellular Binding Proteins for Bone Morphogenetic Protein-2 (*) , 1995, The Journal of Biological Chemistry.
[31] Y. Henis,et al. Different Routes of Bone Morphogenic Protein (BMP) Receptor Endocytosis Influence BMP Signaling , 2006, Molecular and Cellular Biology.
[32] D. Kingsley,et al. What do BMPs do in mammals? Clues from the mouse short-ear mutation. , 1994, Trends in genetics : TIG.
[33] J. Massagué,et al. TGF- SIGNAL TRANSDUCTION , 1998 .
[34] T. Yamazaki,et al. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4. , 2000, Biopolymers.
[35] Joachim Nickel,et al. A single residue of GDF-5 defines binding specificity to BMP receptor IB. , 2005, Journal of molecular biology.
[36] H. Shibai,et al. Expression of erythroid differentiation factor (EDF) in Chinese hamster ovary cells. , 1988, Biochemical and biophysical research communications.
[37] C. Woolf,et al. Repulsive Guidance Molecule (RGMa), a DRAGON Homologue, Is a Bone Morphogenetic Protein Co-receptor* , 2005, Journal of Biological Chemistry.
[38] A. Kotzsch,et al. The solution structure of BMPR-IA reveals a local disorder-to-order transition upon BMP-2 binding. , 2008, Biochemistry.
[39] K. Miyazono,et al. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. , 1993, Oncogene.
[40] J. Massagué,et al. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs , 1995, Molecular and cellular biology.
[41] N. Ueno,et al. Interaction between Soluble Type I Receptor for Bone Morphogenetic Protein and Bone Morphogenetic Protein-4* , 1997, The Journal of Biological Chemistry.
[42] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[43] Roland Baron,et al. BMP‐2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[44] W. Sebald,et al. Molecular recognition of BMP-2 and BMP receptor IA , 2004, Nature Structural &Molecular Biology.
[45] F. Lallemand,et al. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. , 2001, Bone.
[46] A. Reddi,et al. Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. Massagué,et al. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.
[48] T. Hage,et al. Global and Local Determinants for the Kinetics of Interleukin‐4/Interleukin‐4 Receptor α Chain Interaction , 1996 .
[49] J. L. Rosa,et al. JunB Is Involved in the Inhibition of Myogenic Differentiation by Bone Morphogenetic Protein-2* , 1998, The Journal of Biological Chemistry.
[50] A. Kotzsch,et al. Type I receptor binding of bone morphogenetic protein 6 is dependent on N‐glycosylation of the ligand , 2008, The FEBS journal.
[51] T. Hage,et al. Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein. , 1996, European journal of biochemistry.
[52] K. Miyazono,et al. Signal transduction by bone morphogenetic proteins. , 1998, Cytokine & growth factor reviews.
[53] A. Reddi,et al. Role of morphogenetic proteins in skeletal tissue engineering and regeneration , 1998, Nature Biotechnology.
[54] D. Goldenberg,et al. Evaluation of a remote radioiodination system for radioimmunotherapy. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[55] K. Miyazono,et al. Identification of Type I and Type II Serine/Threonine Kinase Receptors for Growth/Differentiation Factor-5* , 1996, The Journal of Biological Chemistry.
[56] B. Hogan,et al. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.
[57] H. Beppu,et al. Repulsive Guidance Molecule RGMa Alters Utilization of Bone Morphogenetic Protein (BMP) Type II Receptors by BMP2 and BMP4* , 2007, Journal of Biological Chemistry.
[58] John C. Lee,et al. Characterization of ligand-binding properties of the human BMP type II receptor extracellular domain. , 2008, Journal of molecular biology.
[59] Charles C Hong,et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.
[60] T. Kirsch,et al. Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP‐2 , 2000, FEBS letters.
[61] T. Jardetzky,et al. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.
[62] Joachim Nickel,et al. Structure Analysis of Bone Morphogenetic Protein-2 Type I Receptor Complexes Reveals a Mechanism of Receptor Inactivation in Juvenile Polyposis Syndrome* , 2008, Journal of Biological Chemistry.
[63] Guang-Quan Zhao,et al. Consequences of knocking out BMP signaling in the mouse , 2003, Genesis.